28 results
PCI in Acute MI with Cardiogenic Shock. #EBM #Cardiology #CULPRITSHOCK #PCI #VisualAbstract #NEJM
PCI in Acute MI ... #EBM #Cardiology ... #CULPRITSHOCK #PCI
Algorithm and Causes of an Elevated Hemidiaphragm #Diagnosis #Radiology #EM #IM #PCC #Elevated #Hemidiaphragm #ElevatedHemidiaphragm #Diaphragm
Hemidiaphragm #Diagnosis #Radiology ... #EM #IM #PCC #Elevated ... Differential #Algorithm #Ddxof
CULPRIT-SHOCK Visual Abstract Infographic

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

https://www.nejm.org/doi/full/10.1056/NEJMoa1710261

CONCLUSIONS:  Among
Infographic PCI ... initially underwent PCI ... #CULPRITSHOCK #PCI ... #Multivessel #EBM ... VisualAbstract #Cardiology
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction (VALIDATE-SWEDEHEART) #EBM #Cardiology #VALIDATE #SWEDEHEART #Bivalirudin #Heparin #PCI #VisualAbstract
VALIDATE-SWEDEHEART) #EBM ... #Cardiology #VALIDATE ... Bivalirudin #Heparin #PCI
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock - Event Rates of the
PCI Strategies in ... #EBM #Cardiology ... #CULPRITSHOCK #PCI
POCUS B-Lines #Clinical #EM #PCC #Radiology #POCUS #BLines #CHF
POCUS B-Lines #Clinical ... #EM #PCC #Radiology
â–º
ISCHEMIA Trial - Management Algorithm for patients with Stable Angina

Stress Test -> ? +moderate or severe
revascularization (PCI ... Management #Algorithm #Cardiology ... #EBM #Trial
Event Rates of the Primary End Point and Its Components at 30 Days #EBM #Cardiology #CULPRIT-SHOCK
Components at 30 Days #EBM ... #Cardiology #CULPRIT-SHOCK ... #CULPRITSHOCK #PCI
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
Dabigatran after PCI ... Fibrillation (RE-DUAL PCI ... warfarin (Panel A) #EBM ... #Cardiology #IM ... TripleTherapy #PCI
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous
2681655 #Policy #EBM ... #Cardiology #Adherence ... Ticagrelor #Plavix #PCI